Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 5, 2004, Pages 626-629

  Di Lernia, Vito ^a   Ricci, C ^a   Albertini, G ^a  

^a Dermatology Unit   (Italy)

Author keywords

Imiquimod; Interferon; Keratoacanthoma; Tumour

Indexed keywords

IMIQUIMOD;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CONDYLOMA; DISEASE DURATION; DRUG APPROVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; KERATOACANTHOMA; PRIORITY JOURNAL; PUNCH BIOPSY; SIDE EFFECT; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; WART VIRUS;

ADMINISTRATION, CUTANEOUS; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CHEEK; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; KERATOACANTHOMA; MIDDLE AGED; SKIN DISEASES;

EID: 4544311618     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.01025.x     Document Type: Article

References (8)

1. Barnetson RS, Halliday GM. Regression in skin tumours: a common phenomenon. Australas J Dermatol 1997; 38 (Suppl. 1): S63-S65.
2. Patel A, Halliday GM, Cooke BE, Barnetson RS. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma. Br J Dermatol 1994; 131: 789-798.
3. Sanchez Yus E, Simon P, Requena L, Ambrojo P, de Eusebio E. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant. Am J Dermatopathol 2000; 22: 305-310.
4. Somlai B, Hollo P. Use of interferon-alpha (IFN-alpha) in the treatment of keratoacanthoma. Hautarzt 2000; 51: 173-175.
5. Stockfleth E, Meyer T, Benninghoff B, et al. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-1502.
6. Wu JK, Siller G, Whitehead K. Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. Australas J Dermatol 2003; 44: 123-125.
7. Eklind J, Tartler U, Maschke J, Lidbrink P, Hengge UR. Imiquimod to treat different cancers of the epidermis. Dermatol Surg 2003; 29: 890-896.
8. Dendorfer M, Oppel T, Wollenberg A, Prinz JC. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 2003; 13: 80-82.